Treatment persistence is greater when switching from other advanced therapies to guselkumab vs to subcutaneous TNFi, IL-17i, or apremilast in PsO.
SCHL's Book Fairs revenues rise 2% to $113.3M in Q3 FY2026 as higher revenue per fair and STEAM-focused Discovery Fairs help ...
Trial by Jury, details the heartbreaking death of Claire Leveque, with her partner, Aren Pearson, accused of murder. Leveque ...
Just as Talladega is synonymous with Dale Earnhardt Sr., Charlotte Motor Speedway is more often than not linked with David ...
Oruka Therapeutics (ORKA) earns a Strong Buy on positive ORKA-001 phase 2a psoriasis data; watch key 2026–2027 catalysts and ...